Midgard Science

Labs / Assays & in vitro testing

Inaphaea BioLabs

Nottingham, United Kingdom · inaphaea.com

GLP

On your own

Free. Their own form.

Contact Inaphaea BioLabs directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Inaphaea BioLabs is a translational contract research organisation based in MediCity, Nottingham, United Kingdom. It provides cell-based assay services for early drug discovery and pre-clinical development, with a focus on oncology and women’s health. The company works with pharma partners and other drug discovery teams on customised assay development and data analysis.

They take quote requests by email.

What they offer

  • Cancer Cell Assays

    Validated and bespoke cancer cell assays to measure cytotoxicity, cell metabolism, apoptosis markers, cell death, cell count, and related drug response readouts.

  • Cell Population Analysis

    Flow cytometry and FACS assay design and implementation for profiling cell cycle, viability, apoptosis, and protein expression in cell populations.

  • Cell Proliferation and Viability Assays

    Assays for cell growth, survival, and death using metabolic, ATP, membrane integrity, nuclear staining, mitochondrial function, DNA synthesis, and high-content imaging readouts.

  • Immunoassays

    Custom immunoassay development, qualification, and validation for measuring hormones, cytokines, cellular activity, and proliferation under stimulation conditions.

  • Biological Modelling and Advanced Statistical Analysis

    Integration of generated data with Physiomics modelling capability for biological modelling and advanced data interpretation.

  • Pre-Formulation and Formulation Development

    Formulation development support integrated with cell-based assays to confirm suitability of molecules and formulation bioactivity.

  • Enzyme Assays

    Contract research services and assay kits for studying DNA-modifying enzyme activity, including screening, IC50 determination, mode of action studies, and custom protein production.

  • AI toxicity prediction

    AI-based drug toxicity prediction service that provides machine-learning outputs interpreted by expert scientists.

  • In-Vitro Liver Cell Assays

    Liver model technology for efficacy and toxicology screening using large-scale generation of hepatocyte-like cells (Opti-Heps).

  • Tissue Based Analysis

    Tissue-based biomarker evaluation including histology, immunohistochemistry, multiplex immunofluorescence, multiplex in situ hybridisation, digital pathology, and image analysis.

What they work on

Modalities
Small molecule, Antibody, Peptide, Recombinant protein
Species and models
human, patient-derived cells, cancer cell lines, chemo-resistance cancer cell lines, 3D spheroid models, 2D monolayers, PBMCs, T cells, B cells, NK cells, macrophages, Opti-Heps
Assays and studies
cytotoxicity, cell metabolism, apoptosis, cell proliferation, cell viability, chequerboard synergy, dose-response, IC50, IC90, cell cycle, FACS, flow cytometry, and 3 more
Instruments and platforms
flow cytometry, FACS, high-content imaging, automated liquid handling systems, RNAScope
Scale and capacity
large-scale generation of hepatocyte-like cells (Opti-Heps), 66 oncology disease indications
Therapeutic areas
oncology, women’s health, drug discovery, pre-clinical development, toxicology screening, efficacy screening
Minimums and prices
fixed pricing for standard, validated assays
Type
CRO
Sites
Nottingham, United Kingdom
Quality
GLP/GCP compliant (tissue based evaluation of biomarkers)

Similar labs. Aurigene Pharmaceutical Services, EyeCRO, MedChem Partners, Sai Life

Found in a contract services directory. Listing built from inaphaea.com. Work here? Claim this listing.

Inaphaea BioLabs · Midgard Science